U014 Melanoma in Special Populations
DESCRIPTION
This session will highlight special high risk and high stakes populations for screening, diagnosing and treating melanoma. We will cover the unique risks to Veterans/military workers, rural patients, pregnant patients, patients with skin of color, and environments affected by COVID-19.
LEARNING OBJECTIVES
Recognize the importance of melanoma risks in military workers/Veterans, rural patients, firefighters, and patients with skin of color
Develop strategies for managing melanoma in challenging clinical situations such as pregnancy and environments affected by COVID-19
SCHEDULE
4:30 PM
Intro to Special Populations
Jennifer G Powers, MD, FAAD
4:40 PM
COVID, Veterans/military populations
Rebecca I Hartman, MD, MPH, FAAD
5:00 PM
Firefighter Advocacy
Christine Kannler, MD, FAAD
5:10 PM
Skin Cancer in Skin of Color and during pregnancy
Jane Margaret Grant-Kels, MD, FAAD
DIRECTOR
Jennifer G Powers, MD, FAAD
SPEAKERS
Jane Margaret Grant-Kels, MD, FAAD
Rebecca I Hartman, MD, MPH, FAAD
Christine Kannler, MD, FAAD
HANDOUTS
DISCLOSURES
Jane Margaret Grant-Kels, MD, FAAD
DermaSensor Inc – Advisory Board(No Compensation Received); VeraDermics Inc. – Board of Directors(No Compensation Received), Founder(No Compensation Received);
Rebecca I Hartman, MD, MPH, FAAD
Almirall – Consultant (1099 relationship)(Fees); Evereden – Advisory Board(Stock), Consultant(Fees); Med Learning Group – Speaker/Faculty Education(Fees); MJH Life Sciences – Consultant (1099 relationship)(Fees); Oasis Pharmaceuticals – Data Safety Monitoring Board(Fees);
Christine Kannler, MD, FAAD
No financial relationships exist with ineligible companies.
Jennifer G Powers, MD, FAAD
Castle Biosciences, Inc – Consultant(Honoraria);